Literature DB >> 8063754

Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density.

P L Prather1, T M McGinn, L J Erickson, C J Evans, H H Loh, P Y Law.   

Abstract

To determine whether the previously demonstrated ability of delta-opioid receptors to interact simultaneously with multiple G-proteins was a function of high receptor levels, this interaction was investigated in Chinese hamster ovary cells stably expressing 10 different levels of cloned delta-opioid receptors, ranging from 18,000 to 1.6 x 10(6) receptors/cell. The opioid agonist D-Ala2,D-Leu5-enkephalin (DADLE) inhibited forskolin-stimulated adenylyl cyclase activity in all 10 clones with variable maximal inhibitory levels. Furthermore, opioid agonists altered incorporation of [alpha-32P]azidoanilido-GTP into at least four G-protein alpha-subunits in all 10 clones, three of which were determined to be Gi3 alpha, Gi2 alpha and Go2 alpha. This effect was concentration-dependent, naloxone-reversible, and delta-opioid agonist-specific and was blocked by pretreatment with pertussis toxin. Although DADLE induced an increase in the incorporation of [alpha-32P]azidoanilido-GTP into three of the four G alpha proteins that was independent of receptor density, the magnitude of this response was greater as receptor density increased. In addition, concentrations of DADLE required to promote 50% maximal labeling were similar for all four G alpha proteins within each clone and did not appear to be affected by receptor density. Therefore, the ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density and there is also no apparent correlation between the amount of G-protein activated and the maximal effect of an agonist.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063754

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity.

Authors:  N T Burford; D Wang; W Sadée
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  [35S]GTP gamma S binding: a tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells.

Authors:  K Befort; L Tabbara; B L Kieffer
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

3.  delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.

Authors:  M Connor; G Henderson
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.

Authors:  S Allouche; J Polastron; A Hasbi; V Homburger; P Jauzac
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

5.  Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.

Authors:  M Shapira; Z Vogel; Y Sarne
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

6.  Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptors.

Authors:  Zhihua Xie; Zhisong Li; Lei Guo; Caiying Ye; Juan Li; Xiaoli Yu; Huifen Yang; Yulin Wang; Chongguang Chen; Dechang Zhang; Lee-Yuan Liu-Chen
Journal:  Eur J Pharmacol       Date:  2007-03-19       Impact factor: 4.432

7.  Cardiac-specific overexpression of human beta2 adrenoceptors in mice exposes coupling to both Gs and Gi proteins.

Authors:  A R G Hasseldine; E A Harper; J W Black
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families.

Authors:  K L Laugwitz; A Allgeier; S Offermanns; K Spicher; J Van Sande; J E Dumont; G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.

Authors:  J M Dickenson; S J Hill
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.

Authors:  K Hidaka; S Tada; M Matsumoto; J Ohmori; Y Tasaki; T Nomura; S Usuda; T Yamaguchi
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.